Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Organisation

Trials

  • NCT06284122

    Collaborator, Phase 3, Active, not recruiting, 790 people, 28 Feb 2024

  • NCT05502250

    Collaborator, Phase 2, Active, not recruiting, 75 people, 16 Aug 2022

  • NCT05049473

    Collaborator, Phase 2, Status unknown, 100 people, 20 Sept 2021

  • NCT03576378

    Phase 1/2, Status unknown, 41 people, 3 Jul 2018

  • NCT02701517

    Phase 2, Terminated, 72 people, 8 Mar 2016

  • NCT02692248

    Phase 2, Completed, 64 people, 26 Feb 2016

  • NCT02682641

    Phase 2, Active, not recruiting, 50 people, 15 Feb 2016

  • NCT02243436

    Phase 1/2, Completed, 67 people, 18 Sept 2014

  • NCT02012088

    Phase 2, Completed, 91 people, 16 Dec 2013

  • NCT01848132

    Phase 2, Completed, 121 people, 7 May 2013

  • NCT01562977

    Phase 2, Completed, 82 people, 26 Mar 2012

  • NCT01133158

    Phase 2, Completed, 61 people, 28 May 2010